A carregar...
Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures
BACKGROUND: Galcanezumab is a monoclonal antibody (mAb) that binds calcitonin gene-related peptide (CGRP) and is indicated for the preventive treatment of migraine. Galcanezumab demonstrated early onset of effect in patients with migraine but it is unknown whether the same holds true for patients wh...
Na minha lista:
| Publicado no: | J Headache Pain |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Milan
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7992932/ https://ncbi.nlm.nih.gov/pubmed/33765912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-021-01230-w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|